HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seborrheic dermatitis.

Abstract
Seborrheic dermatitis is present in 1% to 3% of immunocompetent adults, and is more prevalent in men than in women. Seborrheic dermatitis may be seen in conjunction with other skin diseases, such as rosacea, blepharitis or ocular rosacea, and acne vulgaris. Malassezia yeasts have been associated with seborrheic dermatitis. Abnormal or inflammatory immune system reactions to these yeasts may be related to development of seborrheic dermatitis. Treatment modalities for seborrheic dermatitis include keratolytic agents, corticosteroids, and more recently, antifungal agents. Antifungal agents do not carry a risk of skin atrophy or telangiectasia with prolonged use, and it is more prudent to consider antifungals than corticosteroid preparations. The wide range of antifungal formulations available (creams, shampoos, or oral) provides safe, effective, and flexible treatment options for seborrheic dermatitis.
AuthorsAditya K Gupta, Robyn Bluhm, Elizabeth A Cooper, Richard C Summerbell, Roma Batra
JournalDermatologic clinics (Dermatol Clin) Vol. 21 Issue 3 Pg. 401-12 (Jul 2003) ISSN: 0733-8635 [Print] United States
PMID12956195 (Publication Type: Journal Article, Review)
Chemical References
  • Antifungal Agents
Topics
  • Administration, Cutaneous
  • Administration, Oral
  • Antifungal Agents (administration & dosage, therapeutic use)
  • Dermatitis, Seborrheic (diagnosis, drug therapy, microbiology)
  • Humans
  • Malassezia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: